πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 34 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10000477

Dopamine D3 receptor antagonist compounds

Indivior UK Limited Β· Granted Tue Jun 19 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 14 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9827241

Injectable flowable composition comprising buprenorphine

Indivior UK Limited Β· Granted Tue Nov 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9782402

Injectable composition comprising buprenorphine

Indivior UK Limited Β· Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9687454

Sublingual and buccal film compositions

Indivior UK Limited Β· Granted Tue Jun 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9498432

Injectable flowable composition comprising buprenorphine

Indivior UK Limited Β· Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9486531

Dehydrated hydrogel inclusion complex of a bioactive agent with flowable drug delivery sys

Indivior UK Limited Β· Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9295645

Compositions comprising buprenorphine

Indivior UK Limited Β· Granted Tue Mar 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9272044

Injectable flowable composition buprenorphine

Indivior UK Limited Β· Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9186413

Sustained delivery formulations of risperidone compounds

Indivior UK Limited Β· Granted Tue Nov 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9180197

Sustained delivery formulations of risperidone compounds

Indivior UK Limited Β· Granted Tue Nov 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted